Tag: Public Health Excellence Award

Xingwang Yao | Health Professions | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Mirjana Cvetkovic | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Mirjana Cvetkovic | Health Professions | Best Researcher Award

Consultant CICI and MCS from Great Ormond Street Hospital | United Kingdom

Dr. Mirjana Cvetkovic is an internationally recognised Consultant in Paediatric Cardiac Anaesthesia and Intensive Care at Great Ormond Street Hospital (GOSH), United Kingdom. With over two decades of clinical and academic experience, she has made significant contributions to paediatric critical care, medical simulation, and global health. She has a strong background in ECMO management, perioperative care for children with complex congenital heart diseases, and multidisciplinary education. Her leadership roles include Educational Lead at the Cardiac Intensive Care Unit (CICU) at GOSH, Honorary Lecturer at University College London, and member of the EuroELSO Scientific Committee. Dr. Cvetkovic has pioneered innovative simulation-based training, web-based educational platforms, and advanced perioperative clinical pathways, notably the MIRACCLE initiative. She is deeply committed to humanitarian medical work, having led capacity-building projects for paediatric cardiac care in low-resource settings across Africa and Asia. Her research integrates virtual reality, advanced simulation, and multidisciplinary cardiothoracic education. A prolific educator and active member of numerous professional societies, she continues to shape the next generation of paediatric cardiac specialists. Her career is marked by a commitment to improving patient outcomes, fostering international collaboration, and advancing the science and practice of paediatric cardiac intensive care.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Cvetkovic earned her Medical Doctor degree from the University of Copenhagen, Denmark, followed by specialty education in Anaesthesia and Intensive Care accredited by Styrelsen for Patientsikkerhed, Copenhagen. She achieved her MRCP in Anaesthesia from the Royal College of Anaesthetists, UK completed equivalence to GRID training in Paediatric Intensive Care at GOSH. She further specialised under the Scandinavian Society of Anaesthesiology and Intensive Care (SSAI), undertaking subspecialty training in paediatric and adult anaesthesia and intensive care across Denmark, Sweden, Norway, Finland, and Iceland. She completed a prestigious fellowship in ECMO and Paediatric Cardiac Intensive Care at GOSH. Her academic journey also includes advanced simulation instructor certifications from the University of Copenhagen (CAMES) and Harvard University, Boston. This rigorous and diverse training framework has equipped her with cutting-edge skills in paediatric cardiac anaesthesia, intensive care, simulation-based education, and global health programme design, enabling her to lead transformative initiatives in clinical and educational domains worldwide.

Professional Experience

Dr. Cvetkovic’s career spans multiple leadership and clinical roles in leading healthcare institutions. She has served as Consultant Paediatric Cardiac Anaesthetist and Intensivist at GOSH, where she provides perioperative care and intensive management for children undergoing complex cardiac surgery. She is also an Honorary Lecturer at University College London, actively contributing to the Institute for Cardiovascular Science. Her earlier appointments include Consultant roles at University Hospitals of Leicester, UK, and Locum Consultant in Paediatric Cardiac Anaesthesia at the Royal Hospital for Children, Glasgow. She has held senior fellowships in paediatric intensive care, neonatal care, and ECMO at GOSH and previously worked extensively in Denmark as a Junior Consultant, Specialty Registrar, and Anaesthetist. Dr. Cvetkovic has developed and led major simulation training programmes for multidisciplinary teams, spearheaded international ECMO education at EuroELSO and ESPNIC conferences, and created fast-track surgical recovery pathways. Her global impact extends to humanitarian missions, where she has strengthened paediatric cardiac services in developing countries through structured training, simplified protocols, and team-based education, making her a recognised leader in both clinical excellence and global health advancement.

Research Interests

Dr. Cvetkovic’s research interests focus on paediatric cardiac anaesthesia, intensive care protocols, and extracorporeal life support (ECMO), with a strong emphasis on simulation-based training and education. She is particularly engaged in developing and integrating virtual reality and 3D printing technologies into clinical training for cardiothoracic teams. Her work also explores fast-track recovery pathways for paediatric cardiac surgery, advanced perioperative pain management strategies, and multidisciplinary protocols to enhance patient safety and outcomes. International collaboration is central to her research, as reflected in her MIRACCLE platform, which facilitates knowledge-sharing among global paediatric cardiology and intensive care communities. She contributes to projects aimed at optimising resuscitation courses, improving inter-hospital transport safety, and developing advanced educational models for ECMO and critical care emergencies. Through partnerships with organisations like EuroELSO and ESPNIC, Dr. Cvetkovic is advancing research that bridges cutting-edge medical technology with hands-on clinical application, ensuring that innovations are not only scientifically sound but also feasible for real-world implementation, including in low-resource healthcare systems.

Research Skills

Dr. Cvetkovic possesses a wide range of research and educational skills, integrating clinical expertise with advanced training methodologies. She is proficient in simulation-based research, designing and leading large-scale multidisciplinary training programmes for paediatric cardiac and intensive care teams. Her skills include curriculum development, virtual and augmented reality integration, and educational platform creation (e.g., MIRACCLE). She is experienced in ECMO education, paediatric transoesophageal echocardiography (TOE) training, and developing specialised protocols for perioperative care and cardiac ICU management. She has contributed to international conference workshops, peer-reviewed publications, and collaborative research studies in Scopus and other indexed journals. Her humanitarian project skills include capacity-building strategies, protocol standardisation, and team-training in low-resource settings. She is adept at using structured educational tools like the WHO Surgical Safety Checklist, SAFE communication, and SCAMPs. Dr. Cvetkovic’s ability to combine clinical precision with innovative teaching techniques makes her a highly effective research leader and educator, capable of translating complex clinical concepts into practical, scalable solutions.

Awards and Honours

Dr. Cvetkovic has earned recognition for her exceptional contributions to paediatric cardiac anaesthesia, intensive care, and medical simulation on both national and international platforms. As a EuroELSO Scientific Committee Member, she has influenced the global ECMO education agenda and been invited to lead major simulation-based workshops at EuroELSO, ESPNIC, and EAPS conferences. She has received formal commendations for her humanitarian work in Africa and Asia, where her leadership in establishing sustainable paediatric cardiac units has had lasting health impacts. Her role as an Honorary Lecturer at University College London acknowledges her academic influence, while invitations to deliver lectures and training across Europe, the Middle East, Asia, and Africa demonstrate her global standing. Certification as an Advanced Medical Simulation Instructor by Harvard University and the University of Copenhagen further underscores her excellence in clinical education. She is an active member of leading professional societies including ESPA, SPA, EACTA, SCA, AMEE, IPSS, ESPNIC, DASAIM, and PICS, reflecting her respected status in the field. Her career achievements reflect not only her clinical expertise but also her dedication to global health education and research innovation.

Publication Top Notes

  • “Bridging Europe” advancing Education: The 12th Educational Corner at EuroELSO 2024 conference in Krakow, Poland — 2025

  • “Bridging the Gap” international ECLS training and simulation – evaluation of the 10th educational corner on EuroELSO congress 2022 in London, United Kingdom — 2023

  • Clinical Guidelines for Routine Neuromonitoring in Neonatal and Pediatric Patients Supported on Extracorporeal Membrane Oxygenation — 2023

  • Long-Term Quality of Life in Congenital Heart Disease Surgical Survivors: Multicenter Retrospective Study of Surgical and ICU Explanatory Factors — 2023

  • Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension in a 5-year-old Girl with No Risk Factors — 2022

  • Results of EuroELSO Neurological Monitoring and Neurodevelopmental Outcome Survey — 2021

  • Challenges in Paediatric Cardiac Anaesthesia in Developing Countries — 2018

  • Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery — 2018

  • Brain monitoring in adult and paediatric ECMO patients: the importance of early and late assessments — 2017

  • Real-life use of vasopressors and inotropes in cardiogenic shock-observation is necessarily ‘theory-laden’ — 2016

Conclusion

Dr. Mirjana Cvetkovic is a distinguished clinician, educator, and researcher whose work has transformed paediatric cardiac anaesthesia and intensive care practices worldwide. At Great Ormond Street Hospital, she combines high-level clinical expertise with pioneering educational initiatives that have set new benchmarks in simulation-based medical training. Her MIRACCLE platform and advanced multidisciplinary programmes have significantly improved knowledge exchange in cardiothoracic care. Beyond her institutional role, her humanitarian missions have established sustainable paediatric cardiac services in resource-limited settings, directly impacting countless young lives. Her research seamlessly integrates innovative technologies such as virtual reality and 3D printing with real-world clinical application, contributing to safer, more efficient care pathways. Actively engaged in global collaborations, she influences medical education and practice at an international scale. With her combination of technical skill, academic leadership, and humanitarian dedication, Dr. Cvetkovic exemplifies the qualities of a world-class medical professional and is exceptionally deserving of recognition for her contributions to health professions research and service.

Farid Badria | Health Professions | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Maria Lithoxopoulou | Health Professions | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Maria Lithoxopoulou | Health Professions | Best Researcher Award

Neonatologist -Pediatrics at Faculty of Medicine Aristotle University of Thessaloniki, Greece

Dr. Maria Lithoxopoulou is an esteemed Assistant Professor of Paediatrics-Neonatology at Aristotle University of Thessaloniki, Greece. With over 17 years of clinical experience as a Consultant Neonatologist, she has made significant contributions to neonatal care, focusing on neonatal infections, retinopathy of prematurity, and neonatal nutrition. She holds a Ph.D. in Neonatal Infections and an MBA in Health Administration, showcasing a blend of clinical, research, and administrative expertise. Her research is widely recognized, with 27 published articles, 79 citations, and a Scopus h-index of 5. She has collaborated with various national and international researchers to improve neonatal healthcare outcomes. Her contributions extend beyond neonatology to include ophthalmology, pediatric nutrition, and maternal health, demonstrating a broad and interdisciplinary research approach. Dr. Lithoxopoulou is fluent in Greek and English, with strong technical skills in Microsoft Office and data analysis. Her dedication to academia and research makes her a key figure in advancing neonatal healthcare practices. She is committed to improving neonatal treatment protocols, optimizing drug delivery for preterm infants, and reducing neonatal complications through evidence-based research. With a passion for both clinical and academic excellence, she continues to impact neonatology and pediatrics significantly.

Professional Profile

Education

Dr. Maria Lithoxopoulou has a strong academic background in medicine and healthcare management. She earned her Degree in Medicine from Aristotle University of Thessaloniki, Faculty of Medicine, Greece, in 1994, which laid the foundation for her career in pediatrics and neonatology. She later obtained a License to Practice in Paediatrics in 2003, allowing her to specialize in neonatal care. To further advance her expertise, she pursued a Ph.D. in Neonatal Infections, focusing on Signal Transducer and Activator of Transcription in Neonatal Infection, which she completed in 2012 at Aristotle University of Thessaloniki. In addition to her medical training, she obtained an MBA in Health Administration (2017), which equipped her with the necessary skills to manage and lead healthcare units effectively. She later acquired a Medical Specialty in Neonatology after passing rigorous exams. Her multifaceted education combines clinical, research, and administrative expertise, enabling her to contribute significantly to neonatal medicine, hospital management, and academic research. Dr. Lithoxopoulou’s commitment to education and continuous learning has allowed her to excel in both research and patient care, making her a leading figure in the field of pediatric neonatology.

Professional Experience

Dr. Maria Lithoxopoulou has a distinguished career in neonatology, with extensive experience in both clinical practice and academic research. She began her professional journey as a Consultant Neonatologist at General Hospital of G. Papageorgiou, Aristotle University of Thessaloniki, where she served from 2005 to 2022. During her tenure, she played a critical role in treating preterm and critically ill newborns, optimizing neonatal care protocols, and improving neonatal survival rates. In 2022, she transitioned into academia as an Assistant Professor in Paediatrics-Neonatology at Aristotle University of Thessaloniki, where she continues to mentor medical students, supervise research projects, and contribute to cutting-edge neonatal research. Throughout her career, she has collaborated with multidisciplinary teams in pediatric healthcare, focusing on neonatal infections, retinopathy of prematurity, neonatal nutrition, and early neonatal sepsis management. Her expertise extends to hospital administration, research project management, and neonatal pharmacology, allowing her to bridge the gap between clinical care and medical research. Dr. Lithoxopoulou’s contributions have enhanced neonatal treatment protocols, improved screening techniques for neonatal diseases, and shaped the next generation of neonatologists and pediatricians. Her dedication to both patient care and scientific advancement makes her a leading expert in her field.

Research Interests

Dr. Maria Lithoxopoulou’s primary research interests lie in the field of neonatology, with a strong focus on neonatal infections, neonatal ophthalmology, and neonatal nutrition. She has conducted extensive research on retinopathy of prematurity (ROP), exploring innovative screening techniques, drug delivery methods, and treatment outcomes. Her work also delves into neonatal sepsis, thrombocytopenia, and the effects of maternal health on neonatal outcomes, providing valuable insights into early disease detection and intervention strategies. In addition, she has a growing interest in neonatal pharmacology, particularly in optimizing drug delivery methods for preterm infants to improve treatment efficacy. Dr. Lithoxopoulou is also involved in research concerning pediatric nutrition and the prevention of neonatal malnutrition, emphasizing the role of maternal education in child growth and development. Her interdisciplinary approach has led her to collaborate with researchers in ophthalmology, public health, and biomedical sciences, broadening the impact of her work beyond neonatology. She is committed to advancing evidence-based practices in neonatal care by developing new clinical guidelines, conducting systematic reviews, and engaging in large-scale neonatal health studies. Her research significantly contributes to improving neonatal healthcare standards worldwide.

Research Skills

Dr. Maria Lithoxopoulou possesses advanced research skills in neonatology, clinical trials, and medical data analysis. She has expertise in study design, statistical analysis, and systematic reviews, allowing her to conduct high-quality, evidence-based research. She is proficient in using Scopus, ORCID, and Google Scholar for literature review and citation tracking. Her research skills include quantitative and qualitative data analysis, with experience in handling clinical datasets and patient records to draw meaningful conclusions. She has conducted randomized controlled trials, observational studies, and meta-analyses, particularly in neonatal ophthalmology, neonatal pharmacology, and neonatal infections. Additionally, she is skilled in scientific writing and publishing, with 27 published papers in peer-reviewed journals. She collaborates with multidisciplinary research teams, contributing to studies that impact neonatal healthcare on a global scale. Dr. Lithoxopoulou is also adept at grant writing and securing research funding, helping to advance her work in neonatology. With strong skills in Microsoft Office, PowerPoint presentations, and online research tools, she effectively communicates her findings at national and international conferences. Her expertise in data interpretation and clinical application makes her a valuable asset to neonatal research and academic medicine.

Awards and Honors

Dr. Maria Lithoxopoulou has received recognition for her contributions to neonatology and medical research. She has been acknowledged for her work in neonatal ophthalmology, particularly in improving screening techniques for retinopathy of prematurity (ROP). Her research on neonatal infections and thrombocytopenia has been cited as influential in shaping clinical guidelines for neonatal care. Additionally, she has participated in several national and international research projects, earning grants and funding for her innovative studies. Her dedication to neonatology has also been recognized through invitations to speak at international conferences, where she has presented her findings on neonatal pharmacology, neonatal nutrition, and early disease detection in preterm infants. She has contributed to high-impact medical journals and has played a key role in collaborative neonatal research initiatives. While her h-index (5) and citation count (79) are growing, her research continues to gain recognition in the scientific community. Her commitment to advancing neonatal healthcare through cutting-edge research, academic leadership, and clinical excellence makes her a strong candidate for prestigious research awards in pediatrics and neonatology.

Conclusion

Dr. Maria Lithoxopoulou is a highly accomplished neonatologist and researcher with a strong academic background, extensive clinical experience, and a significant research portfolio. Her work in neonatal infections, ophthalmology, and nutrition has led to valuable advancements in neonatal care and treatment protocols. With 27 research publications, a growing citation impact, and numerous contributions to neonatal medicine, she is a leading expert in her field. While she continues to expand her research influence, her commitment to academia, clinical excellence, and medical innovation makes her an outstanding candidate for the Best Researcher Award.

Publications Top Notes

  • Determination of macronutrient profile and energy composition in human milk via Mid‐Infrared Spectrometer Analysis: An experimental study

    • Authors: Maria Lithoxopoulou, Anastasia Gkampeta, Dimitrios Rallis, Katerina Tzafilkou, Eftychia Drogouti, Christos Tsakalidis
    • Year: 2025

  • A hydrophilic interaction liquid chromatography – Tandem mass spectrometry method for the determination of phenylephrine in dried blood spots from preterm infants

    • Authors: E. Boutou, C. Virgiliou, A.K. Seliniotaki, M. Lithoxopoulou, A. Mataftsi, N. Ziakas, E. Diamanti, N. Raikos, H. Gika
    • Year: 2022

  • Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations

    • Authors: A. Mataftsi, M. Lithoxopoulou, A.K. Seliniotaki, P. Talimtzi, E. Oustoglou, E. Diamanti, V. Soubasi, N. Ziakas, A.-B. Haidich
    • Year: 2022

  • Population-Based Studies in Retinopathy of Prematurity and Screening Criteria Used

    • Authors: Stella Moutzouri, Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Anna-Bettina Haidich, Nikolaos Ziakas, Asimina Mataftsi
    • Year: 2022

  • Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis

    • Authors: D. Rallis, M. Lithoxopoulou, S. Pervana, P. Karagianni, I. Hatziioannidis, V. Soubasi, C. Tsakalidis
    • Year: 2021

  • Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial

    • Authors: A.K. Seliniotaki, M. Lithoxopoulou, P. Talimtzi, E. Georgiou, E. Diamanti, N. Ziakas, A.-B. Haidich, A. Mataftsi
    • Year: 2021

  • Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis

    • Authors: I. Kopsidas, N.-M. Molocha, E. Kourkouni, S. Coffin, D. Gkentzi, E. Chorianopoulou, G. Dimitriou, A. Kapetanaki, G. Karavana, M. Lithoxopoulou, et al.
    • Year: 2021

  • Reducing duration of antibiotic use for presumed neonatal early-onset sepsis in Greek NICUs: A “low-hanging fruit” approach

    • Authors: I. Kopsidas, G.-C. Tsopela, N.-M. Molocha, E. Bouza, E. Chorafa, E. Chorianopoulou, V. Giapros, D. Gkentzi, T. Gkouvas, A. Kapetanaki, et al.
    • Year: 2021

  • A neonate with intrauterine growth restriction and pseudo-Bartter syndrome due to severe maternal eating disorder: A case report

    • Authors: E. Babatseva, I. Chatziioannidis, A.A. Tagaraki, D. Tramma, K. Dampala, E. Chatzitoliou, E. Papacharalambous, G. Mitsiakos, C. Tsakalidis, P. Karagianni, et al.
    • Year: 2020

  • Alternative mydriasis techniques for retinopathy of prematurity screening

    • Authors: A.K. Seliniotaki, E. Prousali, M. Lithoxopoulou, S. Kokkali, N. Ziakas, V. Soubasi, A. Mataftsi
    • Year: 2020

 

Bassem Al Hariri | Health Professions | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr.  Bassem Al Hariri | Health Professions | Best Researcher Award

Assist. Prof. Dr. from Hamad Medical corporation, Qatar

Dr. Bassem Naif Altaleb Alhariri is a distinguished specialist in Internal Medicine and Pulmonary Diseases with extensive experience in clinical practice, medical education, and research. He is currently a Consultant in Internal Medicine & Pulmonology at Hamad Medical Corporation’s Hazm Mebaireek General Hospital in Qatar. Born in Syria on November 1, 1977, Dr. Alhariri has dedicated his career to providing high-quality medical care, mentoring young professionals, and contributing to research in his field. His expertise spans respiratory disorders, emergency medicine, and intensive care, along with a strong background in academic training and committee leadership. With multiple board certifications and international medical licensure, he has made significant contributions to internal medicine and pulmonology.

Professional Profile

Education

Dr. Alhariri earned his MD in General Medicine from Damascus University in 2004. He pursued a specialization in Internal Medicine, receiving his certification from the Syrian Ministry of Health in 2009. Furthering his expertise, he completed a specialization in Pulmonary Diseases in 2013. His postgraduate training included rigorous residency programs at Damascus’s top university hospitals, providing extensive exposure to various medical subspecialties. He holds board certifications in both Internal Medicine and Pulmonary Diseases from the Syrian Board, demonstrating his commitment to excellence in patient care and medical practice.

Professional Experience

Dr. Alhariri has amassed a wealth of experience across multiple medical institutions. He began his career in Syria, serving as a Senior Specialist in Internal Medicine at several government hospitals, later becoming the Head of Department at Izraa Hospital. From 2013 to 2016, he worked as a Consultant in Internal Medicine and Pulmonology, including humanitarian efforts with the International Medical Corps. Since 2017, he has been practicing in Qatar, first at a polyclinic and later at Hamad Medical Corporation. His expertise includes emergency care, intensive care unit (ICU) management, outpatient pulmonary services, and complex diagnostic procedures such as bronchoscopy, thoracoscopy, and lung biopsies.

Research Interests

Dr. Alhariri is deeply involved in medical research, focusing on respiratory disorders, critical care, and emerging treatments in pulmonology. His work includes studying innovative diagnostic techniques and therapeutic approaches for chronic respiratory diseases. As a member of Hamad Medical Corporation’s research committee, he actively contributes to clinical studies and the advancement of evidence-based medicine. His research interests align with improving patient outcomes through novel interventions, medical education strategies, and the integration of advanced diagnostic tools in pulmonary medicine.

Research Skills

Dr. Alhariri possesses strong research skills in clinical case analysis, medical data interpretation, and systematic reviews. His expertise extends to conducting hospital-based research, analyzing patient outcomes, and developing treatment protocols for respiratory conditions. As a reviewer for Clinical Case Reports Journal (Wiley), he critically evaluates medical research publications. His research methodology includes case-control studies, cohort analyses, and qualitative assessments of medical interventions. His ability to integrate clinical practice with research enhances his role as both a physician and an academic mentor.

Awards and Honors

Dr. Alhariri has been recognized for his contributions to medical education, clinical excellence, and research. He has served as an examiner for the Objective-Structured Clinical Exam (OSCE) at Qatar University and as a faculty member at Weill Cornell Medicine-Qatar. His leadership roles include membership in the Clinical Practice Guidelines (CPG) committee and education committees at Hamad Medical Corporation. His dedication to teaching has earned him appointments as a clinical lecturer at Qatar University and an assistant professor at Weill Cornell Medicine-Qatar. These honors reflect his commitment to fostering the next generation of medical professionals.

Conclusion

Dr. Bassem Naif Altaleb Alhariri is a highly accomplished medical professional with a deep passion for patient care, medical education, and research. His extensive experience in internal medicine and pulmonology, combined with his active role in academic training and clinical research, has positioned him as a key contributor to the field. With his unwavering dedication to medical excellence, Dr. Alhariri continues to impact healthcare in Qatar and beyond, shaping the future of respiratory medicine and mentoring aspiring physicians. His commitment to lifelong learning and innovation makes him a respected leader in his specialty.

Publications Top Notes

  1. Case of severe thrombocytopenia with recurrent extensive deep vein thrombosis due to antiphospholipid syndrome, management challenge

    • Authors: Bassem Al Hariri, Gaydaa Ali Ahmed Ali, Arwa Elfatih Mohamed Ali, Mohamed Elfatih MohamedAli, Feroz Jenner Poolakundan, Muhammad Sharif, Memon Noor Illahi
    • Year: 2025

  2. A rare case presentation of gastrointestinal stromal tumor (GIST) in a young adult patient

    • Authors: Bassem Al Hariri, Rawan S. Mohamed, Hadil Altaj Altrify Alsidig, Abdulqadir J. Nashwan, Muad Abdi Hassan
    • Year: 2024

  3. An adolescent presenting with Caroli syndrome associated with polycystic kidney disease: A case report

    • Authors: Bassem Al Hariri, Vajeeha Haider, Memon Noor Illahi, Muhammad Sharif, Abdulqadir J. Nashwan
    • Year: 2024

  4. An idiopathic severe macroglossia in a young adult patient: a rare case

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, Rawan S. Mohamed, Hadil A. A. Alsidig, Hadil A. A. Alsiddig, Memon N. Illahi
    • Year: 2024

  5. Brucellosis an Unusual presentation as isolated septic mono-arthritis of the knee joint: A case report

    • Authors: Muad A. Hassan, F. Noor, A. Salehi, Bassem Al Hariri
    • Year: 2024

  6. Correction to “Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: a case report.”

    • Authors: Bassem Al Hariri, A. Alharafsheh, M. A. Hassan, A. J. Nashwan, M. G. Mohamedali, H. M. Abusriwil
    • Year: 2024

  7. Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial

    • Authors: K. Baagar, T. Alessa, M. Abu-Farha, J. Abubaker, H. Alhumaidi, J.A. Franco Ceruto, M.K. Hamad, A. Omrani, S. Abdelrahman, M. Zaka-Ul Haq, et al.
    • Year: 2024

  8. Periodic Paralysis: A Case Series with a Literature Review

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, O. A. Alsakaji, Y. A. Hassan, M. K. Khalid
    • Year: 2024

  9. Streptococcus cristatus: An uncommon cause for a common hospital admission

    • Authors: U. Al-Anbagi, A. Salehi, G. J. Wilson, F. Noor, A. O. Mohamed, A. Haji, A. J. Nashwan, H. A. Nasir, Bassem A. Hariri
    • Year: 2024

  10. Unusual isolated splenic hydatid cyst: A case report

  • Authors: Bassem Al Hariri, Vajeeha Haider, Mamunul Islam, Abdalrahman Mohammed Mostafa, Ahmad Eid Nazzal Alharafsheh, Memon Noor Illahi
  • Year: 2024

 

Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Healthcare Quality Management, HIV and AIDS at University of Kwazulu-Natal, South Africa

Dr. Tambwe Willy Muzumbukilwa is a distinguished Ph.D. candidate in pharmacology at the University of KwaZulu-Natal, South Africa, with a research focus on healthcare quality management. His primary interest is in enhancing clinical performance and care delivery for individuals living with HIV/AIDS. He holds an MBChB from Université Évangélique en Afrique in the Democratic Republic of Congo and an MSc in Pharmacology from the University of KwaZulu-Natal. As a medical doctor with extensive experience in public health and hospital management, Dr. Muzumbukilwa has demonstrated a commitment to improving healthcare outcomes for vulnerable populations. His leadership roles in various healthcare institutions in the Democratic Republic of Congo, combined with his research on quality indicators for clinical care, have solidified his reputation as a dedicated researcher and practitioner. Dr. Muzumbukilwa is also proficient in laboratory research, focusing on the pharmacological activities of medicinal plants, and has a strong publication record in reputable journals.

Professional Profile

Education

Dr. Muzumbukilwa’s academic journey began with a Bachelor of Medicine and Surgery (MBChB) from Université Évangélique en Afrique, Democratic Republic of Congo. He later pursued a Master of Pharmacology at the University of KwaZulu-Natal, South Africa, where he specialized in the pharmacological properties of medicinal plants. Currently, he is completing his Ph.D. in Pharmacology at the same institution. His doctoral research focuses on healthcare quality management, specifically on developing and evaluating HIV clinical care quality indicators. Dr. Muzumbukilwa’s academic background reflects his dedication to combining clinical expertise with advanced research to address critical healthcare challenges.

Professional Experience

Dr. Muzumbukilwa has held several impactful roles in healthcare management and research. His professional career began with internships at Panzi General Hospital and Lemera General Hospital in the DRC. He later served as a District Health Manager in Minembwe and as a Clinical Manager at Kitutu General Hospital. Additionally, he worked as a Medical Officer at Baraka and Itombwe Hospitals. Since 2017, he has been a researcher at the University of KwaZulu-Natal, focusing on healthcare quality management for individuals living with HIV/AIDS and the hepatoprotective effects of medicinal plants. His extensive experience in leadership and clinical management highlights his ability to address complex public health issues.

Research Interests

Dr. Muzumbukilwa’s research interests center on healthcare quality management and the improvement of clinical care for HIV/AIDS patients. He focuses on developing quality indicators to assess clinical performance and improve health outcomes. His work also extends to laboratory research, particularly the pharmacological activity of medicinal plants in vivo. His interdisciplinary approach bridges clinical and pharmacological research, enabling him to address public health challenges comprehensively.

Research Skills

Dr. Muzumbukilwa possesses a wide range of research skills, including developing and evaluating quality indicators for healthcare performance, conducting systematic reviews, and assessing treatment outcomes. His expertise extends to laboratory techniques, such as pharmacological testing of medicinal plants and animal models for diabetes research. His ability to combine clinical insights with advanced research methodologies has been instrumental in his contributions to healthcare quality improvement.

Awards and Honors

Dr. Muzumbukilwa has been recognized for his academic and research achievements. He received the CHS Scholarship for his postgraduate studies at the University of KwaZulu-Natal in 2018 and 2019, which supported his research on healthcare quality management. Additionally, his work has been widely published in reputable journals, further underscoring his contributions to the fields of pharmacology and public health.

Conclusion

Dr. Tambwe Willy Muzumbukilwa’s combination of academic excellence, professional experience, and innovative research makes him a strong candidate for the Best Researcher Award. His dedication to improving healthcare outcomes for vulnerable populations, particularly those living with HIV/AIDS, and his significant contributions to pharmacological research highlight his impact in the field. With his leadership skills, extensive research background, and commitment to advancing public health, Dr. Muzumbukilwa exemplifies the qualities of an outstanding researcher and healthcare professional.

Publication Top Notes

  1. Developing HIV indicators for clinical care quality assessment: relevance and practicality evaluated by healthcare practitioners in South Africa and Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Manimani, R.G., Vagiri, R.V., Bihehe, M.D., Mushebenge, A.G.A.
    • Journal: BMJ Open Quality
    • Year: 2024
  2. Evaluating compliance with quality indicators of HIV and AIDS clinical care and analyzing those associated with mortality in the Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Dieudonne, B.M., Manimani, R.G., Vagiri, R.V., Nlooto, M.
    • Journal: BMC Infectious Diseases
    • Year: 2024
  3. Assessing the pertinence and usefulness of HIV and AIDS indicators for evaluating clinical care quality: Perspectives of health care professionals
    • Authors: Muzumbukilwa, T.W., Riziki Ghislain, M., Mushebenge, A.G.-A., Vagiri, R.V., Nlooto, M.
    • Journal: African Journal of AIDS Research
    • Year: 2024
  4. Development of a Fundamental Set of Quality Indicators for Evaluating HIV and AIDS Clinical Care: A Systematic Review
    • Authors: Muzumbukilwa, T.W., Ghislain, M.R., Pascal, E.M., Vagiri, R.V., Nlooto, M.
    • Journal: Universal Journal of Public Health
    • Year: 2023
    • Citations: 3
  5. Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis
    • Authors: Riziki Ghislain, M., Muzumbukilwa, W.T., Magula, N.
    • Journal: Medicine (United States)
    • Year: 2023
    • Citations: 3
  6. Mapping the evidence of hepatoprotective properties of Moringa oleifera from sub-Saharan African countries: A systematic review protocol
    • Authors: Muzumbukilwa, W.T., Kadima, M.G., Nlooto, M., Owira, P.M.O.
    • Journal: Systematic Reviews
    • Year: 2019
    • Citations: 7
  7. Hepatoprotective effects of Moringa oleifera Lam (Moringaceae) leaf extracts in streptozotocin-induced diabetes in rats
    • Authors: Muzumbukilwa, W.T., Nlooto, M., Owira, P.M.O.
    • Journal: Journal of Functional Foods
    • Year: 2019
    • Citations: 25

 

 

 

Muheebur Rehman | Health Professions | Excellence in Research

Published on by WSA Awards

Dr. Muheebur Rehman | Health Professions | Excellence in Research

Assistant Professor at Abasyn university Peshawar, Pakistan

Dr. Muheebur Rehman is an Assistant Professor at Abasyn University Peshawar, Pakistan, specializing in applied and industrial physical therapy, rehabilitation medicine, sports science, biomechanics, and kinesiology. With a strong background in clinical physiotherapy, he integrates academic and practical knowledge to foster research in rehabilitation, particularly in cardiopulmonary and musculoskeletal conditions. Known for his goal-oriented and analytical approach, Dr. Rehman is committed to advancing medical research in physical therapy, offering a wealth of experience in both academic teaching and clinical practice. His multifaceted career includes extensive volunteer work, active participation in conferences, and contributions to scientific journals, highlighting his dedication to the growth of his field.

Professional Profile

Education:

Dr. Rehman holds a Master of Science in Cardiopulmonary Physical Therapy from Riphah International University, Islamabad (2019-2021), where he conducted innovative research on the effects of exercise training in lung cancer patients undergoing chemotherapy. Prior to that, he earned a Doctor of Physical Therapy (DPT) degree from Bacha Khan University, Charsadda (2013-2018), with research on non-specific cervical pain in adults. His academic journey reflects his deep commitment to improving rehabilitation strategies, combining advanced academic training with a focus on practical, evidence-based solutions in physical therapy and rehabilitation.

Professional Experience:

Dr. Muheebur Rehman has significant experience in both clinical and academic settings. Since 2020, he has served as an Assistant Professor and Clinical Instructor at Abasyn University Peshawar, where he lectures on rehabilitation medicine and physical therapy. His career includes a range of clinical roles, such as Clinical Physiotherapist at Hafeez Institute of Medical Science (2019-2020) and Clinical Assistant at the Paraplegic Center Hayatabad (2016-2017). Additionally, Dr. Rehman has been involved in various volunteer activities and leadership roles in healthcare and rehabilitation organizations, further underscoring his professional dedication.

Research Interests:

Dr. Rehman’s research focuses on applied physical therapy, specifically cardiopulmonary rehabilitation, musculoskeletal disorders, and the rehabilitation of individuals with chronic conditions. He has contributed to numerous studies on the effects of exercise on cancer patients, musculoskeletal pain, and rehabilitation strategies for conditions such as stroke and rheumatoid arthritis. His research aims to bridge gaps in rehabilitation practices, utilizing evidence-based approaches to enhance patient recovery and quality of life. Additionally, his work extends to improving therapeutic techniques for conditions like low back pain, mobility post-amputation, and post-stroke rehabilitation.

Research Skills:

Dr. Rehman’s research skills are diverse and robust, ranging from literature review and research planning to advanced data analysis. He is proficient in clinical research methodologies, including patient evaluations, data collection, and critical analysis. His skills in data visualization, source evaluation, and problem-solving support his research in physical therapy and rehabilitation. Dr. Rehman also excels in collaboration, regularly working with interdisciplinary teams to develop innovative rehabilitation strategies. His work is supported by a strong foundation in research ethics, critical thinking, and the use of modern tools for data management and presentation.

Awards and Honors:

Dr. Rehman has received several prestigious awards in recognition of his academic excellence and contributions to research. Notably, he earned the Vice Chancellor Research Excellence Award and the Malaysian Conference of Young Scientist Award. His achievements are also marked by merit scholarships at both DPT and MS levels and multiple certifications from leading global institutions, including Harvard Medical School, the University of Melbourne, and the World Health Organization. These honors reflect his commitment to advancing the field of physical therapy through both academic and practical contributions.

Conclusion

Dr. Muheebur Rehman demonstrates significant strengths in both research and clinical practice, contributing valuable insights to the field of physical therapy and rehabilitation. His proactive approach to learning, leadership, and volunteer work further highlights his commitment to advancing his profession. However, expanding his collaborative efforts, increasing his research’s visibility, and pursuing further funding opportunities would strengthen his academic and research profile. Overall, Dr. Rehman is a promising candidate for the Excellence in Research award, with considerable potential for further contributions to his field.

Publication Top Notes

  1. Effects of exercise training in patients with lung cancer during chemotherapy treatment
    Authors: M Rehman, U Ahmad, M Waseem, B Ali, MI Tariq
    Journal: The Malaysian Journal of Medical Sciences (MJMS) 30 (2), 141
    Year: 2023
    Citations: 7
  2. Prevalence of low back pain and disability among computer operators working in the banks of Peshawar: Low back pain and disability among computer operators
    Authors: M Rehman, K Ullah, A Wajid, T Zeb, U Ahmad, F ur Rehman, A Tahir
    Journal: Pakistan Journal of Health Sciences, 87-90
    Year: 2022
    Citations: 3
  3. Prevalence of DeQuervain’s Tenosynovitis among Clinical Physical Therapists in Islamabad: A cross-sectional study
    Authors: S Irfan, M Butt, I Ahmed, H Khalid, R Masood, A Zafar, U Ahmad, …
    Journal: Pakistan Journal of Medical & Health Sciences 17 (05), 42-42
    Year: 2023
    Citations: 1
  4. Functional Outcome of K-Wire Fixation of Supracondylar Fracture of Humerus (Type-III) in the Children Following Six Months
    Authors: AM Komal Mushtaq, Shareen Mehak, Laraib Fatima, Humaira Arshad, Kainat Saif
    Journal: Asian Journal of Science, Technology, Engineering and Art 2 (6), 958-971
    Year: 2024
  5. Clinical Care During the COVID-19 Outbreak Presents Ethical Challenges in Pakistan
    Authors: SA Muheebur Rehman, Faheem Ullah Jan, Zala, Asma Nabi, Shagufta …
    Journal: International Journal of Social Health 3 (11), 766-771
    Year: 2024
  6. To Evaluate the Effect of Prehabilitation Programme on the Quality of Recovery in Pre-Infirmity and Infirm (Frail) Patients Undergoing Heart Valve Surgery
    Authors: MR Tayyaba Kiran, Mehwish Waseem, Pakeeza Batool, Mehwish Iftikhar, …
    Journal: Kurdish Studies 12 (05), 1194-1200
    Year: 2024
  7. The New Frontier in Chronic Illness: Synergizing Biopsychosocial and Mental Health Strategies
    Authors: M Iqra Bukhari, Noorul Ain, Mahin Taelah, Ashmat Ullah, Huda Asif Malik …
    Journal: Journal of Population Therapeutics and Clinical Pharmacology 31 (9), 866-880
    Year: 2024
  8. Translation and Cross-Cultural Adaptation of the Leicester Cough Questionnaire into Urdu: A Descriptive Study
    Authors: DA Urshia Noor, Mehwish Waseem, Naveed Yaqoob, Uzair Ahmad, Muheebur Rehman
    Journal: Remittance Review 9 (4), 1136-1156
    Year: 2024
  9. The Association of Anti-CCP Positivity with Extra-Articular Manifestations in Patients with Rheumatoid Arthritis: Anti-Cyclic Citrullinated Peptide Positivity and Extra
    Authors: ZM Najib Ullah, Abdul Waris, Alam Zeb, Muheebur Rehman, Shawkat Ali …
    Journal: Pakistan Biomedical Journal 7 (7)
    Year: 2024
  10. Investigation of Thyroid Dysfunction Among Hepatitis B & C Patients and Its Association with Interferon Therapy
    Authors: Not provided
    Journal: General Medicine 26 (01), 16
    Year: 2024

 

Dirk Keiner | Health Professions | Innovation Excellence Award

Published on by WSA Awards

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314

 

 

Mona Arafa | Health Professions | Best Researcher Award

Published on by WSA Awards

Assoc Prof Dr. Mona Arafa | Health Professions | Best Researcher Award

Faculty of Pharmacy at University of Tabuk, Saudi Arabia.

Dr. Mona Farouk Mahmoud Arafa is an accomplished Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She earned her Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, focusing on enhancing oral bioavailability through drug crystalline structure modification. With a solid foundation in pharmacy, she has progressed through various academic roles, from Demonstrator to Associate Professor, and actively contributes to departmental committees and quality assurance initiatives. Dr. Arafa’s research interests center on the formulation and evaluation of microemulsions, niosomes, and colloidal systems to improve transdermal drug delivery and oral absorption. She has authored numerous publications in reputable journals and has extensive experience with advanced techniques such as high-performance liquid chromatography and differential scanning calorimetry. Dr. Arafa is committed to advancing pharmaceutical sciences and education, having participated in various training programs to enhance her teaching and research capabilities.

Profile:

Education

Dr. Mona Farouk Mahmoud Arafa holds an impressive educational background in the field of pharmacy and pharmaceutical technology. She earned her Bachelor’s degree in Pharmacy from the University of Tanta, Egypt, in 2009, graduating with a general grade of “Excellent with Honor.” She then pursued her Master’s degree in Pharmaceutical Technology at the same institution, completing her thesis on the optimization of colloidal carriers for the simultaneous transdermal delivery of two drugs in 2013. Dr. Arafa continued her academic journey by obtaining her Ph.D. in Pharmaceutical Technology in 2017, also from the University of Tanta. Her doctoral research focused on the investigation of drug crystalline structure modification as a tool for enhancing oral bioavailability. This strong educational foundation has equipped Dr. Arafa with the knowledge and expertise necessary to excel in her role as an associate professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia.

Professional Experience

Dr. Mona Farouk Mahmoud Arafa is an accomplished academic and researcher in the field of Pharmaceutical Technology, currently serving as an Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She holds a Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, where her research focused on enhancing oral bioavailability through drug crystalline structure modification. Dr. Arafa has progressively advanced through various academic ranks, starting as a Demonstrator and rising to her current position. Her administrative roles include membership in departmental councils, student affairs committees, and quality assurance units. With a strong emphasis on research, Dr. Arafa has authored numerous publications in esteemed journals, contributing to advancements in drug delivery systems, microemulsions, and transdermal formulations. Her expertise is complemented by active participation in training programs and workshops, enhancing her skills in crisis management, international publishing, and digital transformation within higher education.

Research Interest

Dr. Mona Farouk Mahmoud Arafa’s research interests lie in the field of pharmaceutical technology, with a particular focus on enhancing drug delivery systems. Her work involves the formulation, characterization, and evaluation of innovative colloidal carriers, including microemulsions and niosomes, aimed at improving transdermal drug delivery. Dr. Arafa employs advanced analytical techniques such as differential scanning calorimetry, X-ray powder diffraction, and Fourier transform infrared spectroscopy to study the modulation of crystalline structures in drugs. This research is pivotal in understanding how drug interactions with various co-processors can enhance oral bioavailability and absorption. Additionally, she investigates the applications of novel excipients and co-crystal formations to optimize drug dissolution rates. Through her comprehensive approach, Dr. Arafa contributes significantly to the development of advanced pharmaceutical formulations, striving to address challenges in drug delivery and improve therapeutic outcomes for patients.

Research Skills

Dr. Mona Farouk Mahmoud Arafa possesses a robust set of research skills that significantly contribute to her expertise in pharmaceutical technology. Her proficiency in formulating, characterizing, and evaluating various drug delivery systems, including microemulsions and niosomes, showcases her ability to innovate in the field. Dr. Arafa is adept in employing advanced analytical techniques, such as high-performance liquid chromatography, differential scanning calorimetry, and X-ray powder diffraction, to assess drug crystalline structures and enhance oral bioavailability. Her extensive publication record in peer-reviewed journals highlights her capability to conduct rigorous research, analyze complex data, and communicate findings effectively. Additionally, her experience in collaborative research and training programs underscores her commitment to academic excellence and professional development. Dr. Arafa’s skill set not only emphasizes her technical expertise but also reflects her dedication to advancing pharmaceutical sciences and improving patient outcomes through innovative drug delivery systems.

Award and Recognition

Dr. Mona Farouk Mahmoud Arafa, an esteemed Associate Professor in the Pharmaceutics Department at Tabuk University, has received numerous awards and recognitions for her exceptional contributions to pharmaceutical technology. Her groundbreaking research, particularly in the enhancement of oral bioavailability and transdermal drug delivery systems, has been published in high-impact journals, earning her a respected reputation in the academic community. Dr. Arafa’s innovative work on drug crystalline structure modification and the development of novel colloidal carriers has not only advanced scientific understanding but also significantly impacted pharmaceutical practices. She has been actively involved in training programs and workshops, fostering a culture of excellence in education and research. Additionally, her leadership roles within various academic committees reflect her commitment to quality assurance in higher education. Dr. Arafa’s dedication to her field, combined with her extensive research output, underscores her eligibility for recognition as a leading researcher in the pharmaceutical sciences.

Conclusion

Dr. Mona Farouk Mahmoud Arafa is a highly qualified candidate for the Best Researcher Award, exemplifying dedication to research, education, and academic leadership. Her extensive publications, innovative research in drug delivery systems, and administrative roles underscore her commitment to advancing pharmaceutical sciences. By addressing areas for improvement, particularly in networking and public engagement, Dr. Arafa can further elevate her contributions to the field and enhance her influence as a researcher and educator. Recognizing her with this award would not only honor her achievements but also inspire others in the academic community.

Publication Top Notes

  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: SA El-Gizawy, MA Osman, MF Arafa, GM El Maghraby
    • Year: 2015
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2016
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: RK Eid, DS Ashour, EA Essa, GM El Maghraby, MF Arafa
    • Year: 2020
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2018
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2017
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: GM El Maghraby, MF Arafa, MA Osman
    • Year: 2014
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: HF Marei, MF Arafa, EA Essa, GM El Maghraby
    • Year: 2021
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: DA Elmehy, MA Hasby Saad, GM El Maghraby, MF Arafa, NA Soliman, …
    • Year: 2021

 

Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Mr. Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Ph.D. Student at Taipei Medical University, Taiwan.

Bao Tu Thai Nguyen is a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, Taiwan, under the supervision of Assistant Professor Yu-Pin Chen. He also serves as a lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy, Vietnam, and as an attending physician in the Department of Orthopedics and Neurosurgery at the university’s hospital. Bao Tu holds a Bachelor of Medicine and has contributed extensively to orthopedic research, with publications in esteemed journals like World Neurosurgery and EFORT Open Reviews. His work includes meta-analyses on topics such as anterior cervical discectomy, hip fracture mortality, and the impact of smoking on surgical outcomes. Bao Tu has presented at international conferences, including the European Federation of National Societies of Orthopaedics and Traumatology and the Japanese Orthopaedic Association. His research focuses on orthopedic surgery outcomes, biometrics, and predictive modeling in clinical settings.

Profile:

Education

Bao Tu Thai Nguyen is currently pursuing a Ph.D. in Medicine at the International Graduate Program in Medicine, Taipei Medical University, Taiwan, under the guidance of Assistant Professor Yu-Pin Chen. He began his doctoral studies in September 2022, focusing on advancing his expertise in the field of orthopedic surgery and neurosurgery. Prior to his Ph.D., Nguyen earned his Bachelor of Medicine from Can Tho University of Medicine and Pharmacy, Vietnam, where he completed his studies between September 2013 and July 2019. His strong foundation in medical education has equipped him with extensive clinical knowledge, particularly in orthopedics. Throughout his academic journey, Nguyen has demonstrated a deep commitment to research and medical practice, contributing to multiple peer-reviewed publications and international presentations. His ongoing doctoral research aims to further enhance his skills and make meaningful contributions to the field of orthopedic medicine and surgery.

Professional Experience

Bao Tu Thai Nguyen is a Ph.D. student at Taipei Medical University, specializing in orthopedic research. Since June 2020, he has served as a Lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy in Vietnam, where he shares his expertise in orthopedic surgery with medical students. In addition, since December 2020, he has been an Attending Physician in the Department of Orthopedics and Neurosurgery at Can Tho University of Medicine and Pharmacy Hospital. In this role, he provides patient care, performs surgeries, and collaborates with other healthcare professionals to deliver high-quality treatment in orthopedic and neurosurgical cases. His work spans teaching, clinical practice, and research, where he has co-authored multiple peer-reviewed publications on topics such as spinal surgery, joint reconstruction, and trauma management. His dual roles as an academic and practicing physician underscore his dedication to advancing orthopedic healthcare in Vietnam.

Research Interest

Bao Tu Thai Nguyen, a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, focuses his research on orthopedics, with a particular interest in spine surgery, joint reconstruction, and trauma care. His work emphasizes evidence-based approaches, with extensive contributions to meta-analyses on the effectiveness of surgical techniques, such as anterior cervical discectomy and fusion, and the impact of patient factors like smoking on surgical outcomes. Nguyen’s research also delves into innovative treatment methods for fractures and the use of advanced biomaterials in orthopedic surgery, including Polyetheretherketone (PEEK) implants. Additionally, he investigates predictive modeling in orthopedics, such as predicting hamstring graft size for ligament reconstruction based on anthropometric measurements. His commitment to improving surgical outcomes and patient care is evident through his prolific publications and active participation in international conferences, positioning him as a promising researcher in orthopedic and trauma surgery.

Research Skills

Bao Tu Thai Nguyen is a highly skilled researcher with a strong background in orthopedic and neurosurgery research. Currently pursuing a Ph.D. at Taipei Medical University, he has demonstrated expertise in conducting meta-analyses and systematic reviews, as evidenced by his numerous publications in international journals. His research focuses on surgical techniques, implant materials, and risk factors in orthopedic surgery, particularly in spine and fracture management. Bao Tu’s work includes comparative studies of structural allografts versus synthetic materials in surgeries such as anterior cervical discectomy and fusion. He is also proficient in analyzing the impact of lifestyle factors like smoking on surgical outcomes. His proficiency in data analysis, medical statistics, and clinical research methodology has led to several international presentations. Bao Tu’s collaboration with leading academics in Taiwan and Vietnam further highlights his research capabilities, making him a well-rounded and impactful researcher in his field.

Award and Recognition

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Conclusion

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Publication Top Notes

  1. The Association between Red Blood Cell Distribution Width and Mortality Risk after Hip Fracture: A Meta-Analysis
    • Authors: Nguyen, B.T.T.; Tran, D.N.A.; Nguyen, T.T.; Kuo, Y.-J.; Chen, Y.-P.
    • Year: 2024
    • Journal: Medicina (Lithuania)
    • Volume/Issue: 60(3), 485
    • Citations: 3
  2. Adverse Effect of Smoking on Surgical Site Infection following Ankle and Calcaneal Fracture Fixation: A Meta-Analysis
    • Authors: Tran, D.N.A.; Nguyen, B.T.T.; Nguyen, T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: EFORT Open Reviews
    • Volume/Issue: 9(8), pp. 817–826
  3. Is Smoking a Risk Factor for Complications Following Total Ankle Arthroplasty? A Meta-Analysis
    • Authors: Le, Y.T.T.; Tran, D.N.A.; Nguyen, B.T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: Foot and Ankle Surgery (Article in Press)
  4. Two-port Endoscopic Surgery for Carpal Tunnel Syndrome – A Prospective Cohort Study
    • Authors: Nguyen, T.T.; Duong, K.; Tran, S.Q.; Ly, H.H.V.; Nguyen, B.T.T.
    • Year: 2022
    • Journal: Malaysian Orthopaedic Journal
    • Volume/Issue: 16(2), pp. 55–62
    • Citations: 2